Grace Therapeutics, Inc. (GRCE) › Shareholders' EquityGrace Therapeutics, Inc. (GRCE) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: $7.19M2019: $11.04M2020: $12.99M2021: $55.66M2022: $108.27M2023: $67.95M2024: $61.74M2025: $66.61M$66.61M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$66.61M+7.9%2024$61.74M-9.1%2023$67.95M-37.2%2022$108.27M+94.5%2021$55.66M+328.4%2020$12.99M+17.6%2019$11.04M+53.6%2018$7.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share